A request for a “fully compliant lab network” hides several decisions: compliant with which requirements, for which records, in which operations, and with whose approval? A stronger brief identifies the intended use and the evidence needed to support it. Mytek can scope infrastructure, technical controls and reporting around those requirements. The client’s quality, regulatory and legal owners determine applicability, approve procedures and decide what qualification or validation is required.
Establish applicability before collecting evidence
FDA’s Part 11 guidance ties its scope to electronic records required by applicable predicate rules and certain electronic submissions. Using a computer in a biotech facility does not, by itself, make every file a Part 11 record. Inventory the relevant processes and records with their owners, then identify which systems create, change, maintain or transmit them.
Different operations can have different obligations within one company. FDA’s GLP definitions exclude basic exploratory research from the defined nonclinical laboratory studies in that context. HIPAA also depends on covered-entity or business-associate status and relevant activities; a research company is not automatically covered simply because its work relates to health. Document the determination instead of using an industry label as the answer.
Build a control-to-evidence register
For each client-identified requirement, record the system, intended control, responsible owner, evidence source and review cadence. A useful register also states the limits of the evidence. A backup-job success log shows a job outcome; it does not establish that the intended workflow can be restored. An access list shows assigned permissions at a point in time; it does not prove every assignment was approved.
Use explicit status labels such as implemented, tested, exception pending and not in scope. Keep the reviewer, date and next action with each entry. A framework report should expose missing evidence and unresolved decisions, rather than turn an incomplete assessment into an assurance statement.
Distinguish four kinds of project evidence
Installation records identify what was installed and where. Commissioning records document agreed functional checks. Qualification and validation involve additional client-defined activities and acceptance requirements when applicable. FDA’s process-validation guidance addresses a lifecycle for applicable drug manufacturing; do not collapse those activities into the installer’s completion checklist.
Agree which documents Mytek will provide, which come from equipment vendors and which the client prepares or approves. Examples include cable test reports, network diagrams, configuration baselines, asset registers and support responsibilities. Do not label those deliverables a validated facility unless the responsible client process has actually established that conclusion.
Preserve the context around records
For applicable drug CGMP operations, FDA’s data-integrity guidance emphasizes reliable records and the context needed to reconstruct activities. Scope access, changes, review, retention and retrieval with the records owner. Determine what metadata is necessary and how it travels with authorized exports or backups.
A camera export, a sensor graph and a laboratory application audit trail can serve different purposes. Identify the authoritative record for each use rather than merging them into one undefined compliance dashboard. Have the intended reviewer test an example retrieval before approving the handover format.
Keep reporting current after handover
Changes to staff, instruments, network rules and vendors can invalidate assumptions made during a buildout. Define when an access review, configuration review or recovery test should be repeated. The managed IT scope should identify who collects evidence, who reviews it and who accepts any remaining risk.
Prepare a review pack containing a current inventory, approved diagrams, change records, patch exceptions, relevant monitoring results and outstanding actions. Lab network and managed IT planning provides the operational starting point. Technical reporting supports the client’s compliance program; it does not confer FDA certification or guarantee an audit outcome.
Discuss your facility
Explore technology infrastructure for California life sciences facilities or discuss your scope with Mytek Pros. Share your location, project phase and the systems involved. Keep research data, credentials and sensitive records out of the initial inquiry.